BeStock  
Stocks › Biotechnology › KOD

Kodiak Sciences KOD

US equityMarket cap rank #1807Biotechnology
$97.17 −$0.73 (-0.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $97.26 +0.09%
Open$97.00
Prev close$97.90
Day range$96.53 – $100.89
Volume693.1K
Market cap$6.35B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±7.2%last 4 reports
Closed higher1 of 425% of the time
Best reaction+3.6%
Worst reaction-15.4%

Stock move on the day after each report

-6.1%2019/Q3-3.7%2020/Q1+3.6%2020/Q3-15.4%2023/Q4
QuarterReport dateTimingImplied moveActual moveVersus implied
2023/Q428 Mar 2024None±26.8%-15.40%Within range
2020/Q39 Nov 2020None±15.5%+3.62%Within range
2020/Q112 May 2020After Market±15.9%-3.66%Within range
2019/Q312 Nov 2019Pre Market–-6.10%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$67.10M-7.6% YoY
Net profit-$66.22M-7.8% YoY
Diluted EPS-$1.05+9.5% YoY
Free cash flow-$45.85M-39.2% YoY
Operating cash flow-$43.87M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-44.1MDec '24$-57.5MMar '25$-54.3MJun '25$-61.5MSep '25$-56.7MDec '25$-58.2MMar '26$-65.6MJun '26$-66.2MSep '26

Profitability & balance sheet

Return on equity-1,360.9%
Return on assets-115.4%
Return on invested capital-346.6%
Current ratio1.70
Liabilities / assets94.0%
Cash & investments$88.68M
Total debt$41.28M
Net cash (debt)$47.40M

Discussion

No comments yet — be the first to weigh in on KOD.

Sign in to join the discussion.

Scroll to Top